IIT RESEARCH INSTITUTE

Reduce your risk when donating: see where the money actually goes.

Reduce your risk when donating: see where the money actually goes.

Cite this

Plain text IIT RESEARCH INSTITUTE. furp.org, nonprofit organization profile, tax years 2019–2024. https://furp.org/org/iit-research-institute-362169122. Retrieved 2026-11-16.

APA furp.org. (n.d.). IIT RESEARCH INSTITUTE [Nonprofit organization profile; tax years 2019–2024]. Retrieved November 16, 2026, from https://furp.org/org/iit-research-institute-362169122

MLA “IIT RESEARCH INSTITUTE.” furp.org, tax years 2019–2024, https://furp.org/org/iit-research-institute-362169122. Accessed 16 Nov. 2026.

Retrieved 2026-11-16; covers tax years 2019–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).

About (Wikipedia)

IIT Research Institute · American think tank

IIT Research Institute (IITRI), also known historically and interchangeably as IIT Research Center, is a high-technology scientific research organization and applied research laboratory located in Chicago, Illinois.

Founded
1936
Headquarters
Chicago
Type
business
Website
http://www.iitri.org

From Wikipedia, CC BY-SA 4.0 (authors and history); facts from Wikidata (CC0). Matched by the same website address and the same name. Report a wrong match · About this data

2024 · Form 990 · revenue $17.5M ($18.0M in 2025 dollars) · expenses $23.0M · assets $36.3M

EIN
36-2169122
Address
10 WEST 35TH STREET, CHICAGO, IL 60616-3717
Website
www.iitri.org
NTEE code
U20 General Science (Science and Technology) published (IRS Business Master File, as U200)
FURP topic
science: research education (from its 990 text; the topic index)
Exempt type
501(c)(3): charitable, religious, educational, scientific or literary (corporation)
Ruling date
March 1941 (when the IRS recognized its exemption)
IRS status
Exempt (unconditional) (IRS Business Master File) IRS data ↗
Tax-deductible donations
Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
Foundation status
Public charity, 509(a)(2)
Cross-check
ProPublica Nonprofit Explorer

Mission

Perform basic research and preclinical efficacy assessments of new molecular entities being developed for the prevention and treatment of cancer and infectious disease. Discover new pathways and targets for the design and development of new small molecule therapeutics and biotherapeutic agents.

Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).

People paid by the organization

21 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.

NameLatest titleYearsLatest year payTotal pay from hereOrganizations
David McCormick President & Director2019-2024 $581,526$2,642,741 1
Todd Bucciarelli AVP & Business Development Manager2019-2024 $311,525$1,583,594 1
Robert Baker AVP & Mgr Microbiology & Molecular Biology2019-2024 $265,932$1,403,592 1
Thomas Horn Deputy Division Manager Toxicology2019-2024 $245,251$1,172,089 1
Kelly Garcia Attending Veterinarian2021-2024 $254,458$982,703 1
Nicole Kozub Laboratory Biologist IV/Supervisor2021-2024 $191,702$810,878 1
David Kaplan Assistant Vice President & Director of Contracts2022-2024 $232,058$664,315 1
Landon Westfall Deputy Division Manager2022-2024 $201,016$589,391 1
Aleemuddin Muhammad Manager of IT & Cybersecurity2022-2024 $198,611$587,574 1
Sudhakar Parthasarathy Head, Analytical Chemistry2023-2024 $224,496$430,225 1
Mary Smeaton Manager, Human Resources2023-2024 $176,157$349,542 1
Myron H Powelson IV Director, Finance & Accounting2024 $218,072$218,072 1
William Johnson (former) AVP & Manager Toxicology2019-2022 $268,461$880,278 1
Miguel Muzzio (former) VP & Deputy Director, Mgr Analytical Chemistry2019-2021 $239,771$627,566 1
Glenn Miller (former) AVP & QA Manager2019-2021 $178,574$492,459 1
Sridhar Jaligama (former) Deputy Division Manager/Study Director2021-2022 $226,218$410,018 1
Ethan H Landesman (former) Director of Finance & Accounting2020-2021 $216,332$381,474 1
Theodore Francis (former) Manager IT & Cyber Security2019-2020 $157,661$313,746 1
Michael McGibbon (former) VP & Director for Administration2019-2020 $112,434$271,019 1
Narayanan Rajendran (former) VP & Mgr Inhalation Toxicology2019 $170,430$170,430 1
Tate W Brummitt (former) Director of Contracts & Procurement2020 $146,919$146,919 1

Officers and directors, no compensation reported

11 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.

NameLatest titleYearsHrs/wk (latest)CompensationOrganizations
Walter Hazlitt Secretary & Interim General Counsel2020-2024 0 $0 reported 2
Rajagopal R Echambadi Chairman & CEO2020-2024 0 $0 reported 1
Jeremy Fine Treasurer, VP Finance & CFO2023-2024 0 $0 reported 2
Elizabeth Hudson Provost, SVP Academic Affairs & Member2023-2024 0 $0 reported 1
Angela Manning-Hardiman (former) Treasurer, VP Finance & CFO2020-2022 0 $0 reported 1
Kenneth T Christensen (former) Provost, SVP Academic Affairs & Member2020-2022 0 $0 reported 1
Alan Cramb (former) Chairman, CEO & President2019 1 $0 reported 7
Peter Kilpatrick (former) Member, Board of Governors2019 1 $0 reported 2
Anthony D'Amato (former) Secretary, VP & General Counsel2019 1 $0 reported 3
Michael D Horan (former) Treasurer, VP & CFO2019 1 $0 reported 1
Mary Ellen Borchers (former) Interim VP of Finance2019 1 $0 reported 1

People by year

2024 · 16 people listed · 12 paid, $3.1M · 128 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President & Director40 $532,005$0$49,521 $581,5261
Todd Bucciarelli AVP & Business Development Manager40 $262,728$0$48,797 $311,5251
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $225,381$0$40,551 $265,9321
Kelly Garcia Attending Veterinarian40 $211,693$0$42,765 $254,4581
Thomas Horn Deputy Division Manager Toxicology40 $202,154$0$43,097 $245,2511
David Kaplan Assistant Vice President & Director of Contracts40 $206,800$0$25,258 $232,0581
Sudhakar Parthasarathy Head, Analytical Chemistry40 $198,793$0$25,703 $224,4961
Myron H Powelson IV Director, Finance & Accounting40 $174,668$0$43,404 $218,0721
Landon Westfall Deputy Division Manager40 $174,720$0$26,296 $201,0161
Aleemuddin Muhammad Manager of IT & Cybersecurity40 $156,618$0$41,993 $198,6111
Nicole Kozub Laboratory Biologist IV/Supervisor40 $164,176$0$27,526 $191,7021
Mary Smeaton Manager, Human Resources40 $145,725$0$30,432 $176,1571
Rajagopal R Echambadi Chairman & CEO0 $0$0$0 $01
Walter Hazlitt Secretary & Interim General Counsel0 $0$0$0 $02
Jeremy Fine Treasurer, VP Finance & CFO0 $0$0$0 $02
Elizabeth Hudson Provost, SVP Academic Affairs & Member0 $0$0$0 $01
2023 · 15 people listed · 11 paid, $2.7M · 127 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President & Director40 $377,150$0$74,696 $451,8461
Todd Bucciarelli AVP & Business Development Manager40 $280,549$0$55,430 $335,9791
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $213,339$0$40,711 $254,0501
Kelly Garcia Attending Veterinarian40 $206,845$0$44,338 $251,1831
Nicole Kozub Laboratory Biologist IV/Supervisor40 $200,403$0$30,103 $230,5061
Thomas Horn Deputy Division Manager Toxicology40 $178,970$0$43,127 $222,0971
David Kaplan Assistant Vice President & Director of Contracts40 $189,311$0$25,566 $214,8771
Sudhakar Parthasarathy Head, Analytical Chemistry40 $190,529$0$15,200 $205,7291
Aleemuddin Muhammad Manager of IT & Cybersecurity40 $155,491$0$45,701 $201,1921
Landon Westfall Deputy Division Manager40 $167,079$0$26,087 $193,1661
Mary Smeaton Manager, Human Resources40 $138,201$0$35,184 $173,3851
Rajagopal R Echambadi Chairman & CEO0 $0$0$0 $01
Walter Hazlitt Secretary & Interim General Counsel0 $0$0$0 $02
Jeremy Fine Treasurer, VP Finance & CFO0 $0$0$0 $02
Elizabeth Hudson Provost, SVP Academic Affairs & Member0 $0$0$0 $01
2022 · 15 people listed · 11 paid, $2.8M · 157 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President & Director40 $422,808$0$42,266 $465,0741
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $233,707$0$38,030 $271,7371
William Johnson AVP & Manager Toxicology40 $230,851$0$37,610 $268,4611
Todd Bucciarelli AVP & Business Development Manager40 $218,622$0$45,485 $264,1071
Kelly Garcia Attending Veterinarian40 $208,494$0$39,812 $248,3061
Sridhar Jaligama Deputy Division Manager/Study Director40 $174,716$0$51,502 $226,2181
David Kaplan Assistant Vice President & Director of Contracts40 $199,903$0$17,477 $217,3801
Thomas Horn Deputy Division Manager Toxicology40 $175,935$0$38,959 $214,8941
Nicole Kozub Laboratory Biologist IV/Supervisor40 $173,579$0$24,918 $198,4971
Landon Westfall Deputy Division Manager40 $178,875$0$16,334 $195,2091
Aleemuddin Muhammad Manager of IT & Cybersecurity40 $152,312$0$35,459 $187,7711
Rajagopal R Echambadi Chairman & CEO0 $0$0$0 $01
Walter Hazlitt Secretary & Interim General Counsel0 $0$0$0 $02
Angela Manning-Hardiman Treasurer, VP Finance & CFO0 $0$0$0 $01
Kenneth T Christensen Provost, SVP Academic Affairs & Member0 $0$0$0 $01
2021 · 15 people listed · 11 paid, $2.7M · 152 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President & Director40 $406,233$0$42,385 $448,6181
Todd Bucciarelli AVP & Business Development Manager40 $269,090$0$47,188 $316,2781
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $213,349$0$35,475 $248,8241
William Johnson AVP & Manager Toxicology40 $205,448$0$36,792 $242,2401
Miguel Muzzio VP & Deputy Director, Mgr Analytical Chemistry40 $215,356$0$24,415 $239,7711
Kelly Garcia Attending Veterinarian40 $195,389$0$33,367 $228,7561
Ethan H Landesman Director of Finance & Accounting40 $195,090$0$21,242 $216,3321
Thomas Horn Deputy Division Manager Toxicology40 $160,077$0$37,041 $197,1181
Nicole Kozub Laboratory Biologist IV/Supervisor40 $166,734$0$23,439 $190,1731
Sridhar Jaligama Deputy Division Manager/Study Director40 $148,751$0$35,049 $183,8001
Glenn Miller AVP & QA Manager40 $169,139$0$9,435 $178,5741
Rajagopal R Echambadi Chairman & CEO1 $0$0$0 $01
Walter Hazlitt Secretary & Interim General Counsel1 $0$0$0 $02
Angela Manning-Hardiman Treasurer, VP Finance & CFO1 $0$0$0 $01
Kenneth T Christensen Provost, SVP Academic Affairs & Member1 $0$0$0 $01
2020 · 15 people listed · 11 paid, $2.0M · 150 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President & Director40 $341,800$0$20,137 $361,9371
Miguel Muzzio VP & Deputy Director, Mgr Analytical Chemistry40 $191,623$0$11,317 $202,9401
Todd Bucciarelli AVP & Business Development Manager40 $182,103$0$10,497 $192,6001
William Johnson AVP & Manager Toxicology40 $180,828$0$10,705 $191,5331
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $178,064$0$11,002 $189,0661
Ethan H Landesman Director of Finance & Accounting40 $162,407$0$2,735 $165,1421
Glenn Miller AVP & QA Manager40 $152,751$0$8,811 $161,5621
Theodore Francis Manager IT & Cyber Security40 $148,226$0$9,435 $157,6611
Thomas Horn Deputy Division Manager Toxicology40 $143,246$0$8,938 $152,1841
Tate W Brummitt Director of Contracts & Procurement40 $146,573$0$346 $146,9191
Michael McGibbon VP & Director for Administration40 $105,813$0$6,621 $112,4341
Rajagopal R Echambadi Chairman & CEO1 $0$0$0 $01
Walter Hazlitt Secretary & Interim General Counsel1 $0$0$0 $02
Angela Manning-Hardiman Treasurer, VP Finance & CFO1 $0$0$0 $01
Kenneth T Christensen Interim Provost, SVP Academic Affairs & Member1 $0$0$0 $01
2019 · 15 people listed · 10 paid, $1.8M · 130 employees · 0 volunteers
NameTitleHrs/wkFrom orgFrom relatedOtherTotalOrgs
David McCormick President40 $314,790$0$18,950 $333,7401
Miguel Muzzio VP & Deputy Director, Mgr Analytical Chemistry40 $174,188$0$10,667 $184,8551
William Johnson AVP & Manager Toxicology40 $167,916$0$10,128 $178,0441
Robert Baker AVP & Mgr Microbiology & Molecular Biology40 $163,702$0$10,281 $173,9831
Narayanan Rajendran VP & Mgr Inhalation Toxicology40 $160,506$0$9,924 $170,4301
Todd Bucciarelli AVP & Business Development Manager40 $153,667$0$9,438 $163,1051
Michael McGibbon VP & Director for Administration40 $149,091$0$9,494 $158,5851
Theodore Francis Manager IT & Cyber Security40 $146,997$0$9,088 $156,0851
Glenn Miller AVP & QA Manager40 $143,758$0$8,565 $152,3231
Thomas Horn Deputy Division Manager Toxicology40 $132,175$0$8,370 $140,5451
Alan Cramb Chairman, CEO & President1 $0$0$0 $07
Anthony D'Amato Secretary, VP & General Counsel1 $0$0$0 $03
Michael D Horan Treasurer, VP & CFO1 $0$0$0 $01
Peter Kilpatrick Member, Board of Governors1 $0$0$0 $02
Mary Ellen Borchers Interim VP of Finance1 $0$0$0 $01

Highest-paid independent contractors

2024 · 5 contractors · $3.9M
NameLocationServicePaid
Charles RiverWilmington, MAPathology services$3,035,000
McCauley Mechanical ConstructionBridgeview, ILConstruction Services$309,000
Petrovic EnterprisesDowners Grove, ILConstruction Services$287,000
NeuroScience Associates IncKnoxville, TNPathology services$151,000
Marshall BioResourcesNorth Rose, NYLab Animal Services$145,000
2023 · 5 contractors · $9.5M
NameLocationServicePaid
Charles RiverWilmington, MAPathology services$4,332,000
McCauley Mechanical ConstructionBridgeview, ILConstruction Services$2,504,000
WORLDWIDE PRIMATES INCMiami, FLLab Animal Services$1,824,000
Petrovic EnterprisesDowners Grove, ILConstruction Services$601,000
Ridglan Farms IncGlenbeulah, WILab Animal Services$219,000
2022 · 5 contractors · $8.9M
NameLocationServicePaid
McCauley Mechanical ConstructionBridgeview, ILConstruction Services$4,538,000
Charles RiverWilmington, MAPathology services$3,014,000
Petrovic EnterprisesDowners Grove, ILConstruction Services$649,000
Ridglan Farms IncGlenbeulah, WILab Animal Services$366,000
STARLIMS CorporationSouth Hollywood, FLClinical Reporting Services$288,000
2021 · 5 contractors · $9.4M
NameLocationServicePaid
McCauley Mechanical ConstructionBridgeview, ILConstruction Services$4,049,000
Charles RiverWilmington, MAPathology services$3,021,000
Petrovic EnterprisesDowners Grove, ILConstruction Services$793,000
Bear Construction CompanyRolling Meadows, ILConstruction Services$792,000
ENVIGO GLOBAL SERIVICESIndianapolis, INLab Services$726,000
2020 · 5 contractors · $3.6M
NameLocationServicePaid
Charles RiverWilmington, MAPathology services$1,554,000
Texas Biomedical ResearchSan Antonio, TXClinical Rptg Services$1,321,000
Triple F Farms IncGillett, PALab Animal Services$246,000
Ridglan Farms IncBlue Mounds, WILab Animal Services$246,000
University of Oklahoma Health Science CtrOklahoma City, OKClinical Reporting Services$234,000
2019 · 5 contractors · $3.3M
NameLocationServicePaid
Charles RiverWilmington, MAPathology services$2,575,000
University of Oklahoma Health Science CenterOklahoma City, OKClinical Rptg Services$234,000
Messina Group IncChicago, ILStaffing services$167,000
Dust Em Clean MaintenanceChicago, ILJanitorial Services$147,000
Momentum Scientific StaffingChicago, ILStaffing Services$139,000

Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.

YearPaid byServicePaidFiling
2018ACCESS TO ADVANCED HEALTH INSTITUTERESEARCH$206,285view vendor page

Who gave

Contributor names are not public for this form type.

Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.

Finances

Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.

RevenueExpensesAssetsNet assetsContributionsProgram revenueOfficer payEmployeesVolunteers
2024 · Form 990 period ending 2025-09-30 · view filing · original 990 ↗
$17,520,000$23,019,000 $36,279,000$24,890,000 $0$17,444,000 $1,689,0001280
2023 · Form 990 period ending 2024-09-30 · view filing · original 990 ↗
$28,657,000$27,336,000 $42,170,000$30,391,000 $0$28,520,000 $1,858,0001270
2022 · Form 990 period ending 2023-09-30 · view filing · original 990 ↗
$27,838,000$25,988,000 $43,645,000$28,943,000 $0$27,749,000 $2,758,0001570
2021 · Form 990 period ending 2022-09-30 · view filing · original 990 ↗
$29,871,000$25,493,000 $44,213,000$27,015,000 $0$29,810,000 $1,505,0001520
2020 · Form 990 period ending 2021-09-30 · view filing · original 990 ↗
$29,119,000$25,975,000 $42,081,000$22,800,000 $0$29,028,000 $1,933,0001500
2019 · Form 990 period ending 2020-09-30 · view filing · original 990 ↗
$26,941,000$25,017,000 $32,512,000$19,626,000 $0$26,793,000 $799,0001300

Connected to

Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.

Funders of this organization

4 grantors reported grants to this organization, $2,464,157 in all, tax years 2011 to 2021. Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV

GrantorTotal givenGrantsLatest year's amountLatest yearYears givenTypeMatchGrants
UNIVERSITY OF CHICAGO $2,222,6437 $41,9142021 2014-2016, 2018-2021 Public charity Exact
show
UNITED NEGRO COLLEGE FUND INC $147,0583 $34,9792013 2011-2013 Public charity Exact
show
VANDERBILT UNIVERSITY $70,4562 $35,2282012 2011-2012 Public charity Exact
show
LEGACY GLOBAL FOUNDATION INC $24,0001 $24,0002016 2016 DAF sponsor Exact
show

Nearby + Similar BETA

Organizations like this one: what they do and who they are linked to

Same category: NTEE code and revenue

Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)

OrganizationStateNTEELatest revenueLatest expensesTop-paid titleTop payWhy similar
INSTITUTE FOR CREATION RESEARCHTXU20 $10,363,954$10,643,510 PRESIDENT/TRUSTEE$196,200 Same NTEE code U20, revenue within 2x, similar name
WEST VIRGINIA STATE UNIVERSITY RESEARCH AND DEVELOPMENT CORPWVU20 $21,949,840$21,431,082 VICE CHAIR$203,995 Same NTEE code U20, revenue within 2x
CLIMATE CENTRAL INCNJU20 $22,272,608$11,535,677 CEO & CHIEF SCIENTIST$391,991 Same NTEE code U20, revenue within 2x
SPARK NS INCCAU20 $9,000,000$6,368,774 EXECUTIVE DIRECTOR$378,462 Same NTEE code U20, revenue within 2x
UNIVERSITY LICENSE EQUITY HOLDINGS INCCOU20 $19,670,419$2,218,535 TREASURER/SECRETARY (THRU 05/24)$686,410 Same NTEE code U20, revenue within 2x
PATUXENT PARTNERSHIP INCMDU20 $9,556,202$9,381,272 IPA EMPLOYEE$255,032 Same NTEE code U20, revenue within 2x
ACADEMY OF MANAGED CARE PHARMACY A NEW JERSEY NONPROFIT CORPORATIONVAU20 $20,869,863$23,638,943 Chief Executive Officer$971,276 Same NTEE code U20, revenue within 2x
ENERGETICS TECHNOLOGY CENTER INCMDU20 $28,407,479$28,244,901 President & COO$291,608 Same NTEE code U20, revenue within 2x
ST LOUIS SCIENCE CENTER FOUNDATIONMOU20 $10,815,081$9,659,434 PRESIDENT / CEO (AS OF 2/25)$373,441 Same NTEE code U20, revenue within 2x
VIRGINIA HEALTH INFORMATIONVAU20 $13,708,032$11,975,971 CHIEF EXECUTIVE OFFICER$321,625 Same NTEE code U20, revenue within 2x
FAJR SCIENTIFICTXU20 $18,174,508$13,201,857 CEO$230,000 Same NTEE code U20, revenue within 2x
IQM RESEARCH INSTITUTEMIU20 $4,600,511$4,561,763 VP OF ADVANCE PROGRAMS$333,281 Same NTEE code U20, revenue within 5x, similar name
MIND RESEARCH INSTITUTE INCCAU20 $5,670,095$7,550,544 CHIEF EXECUTIVE OFFICER$473,438 Same NTEE code U20, revenue within 5x, similar name
NORTHWEST INSTITUTE OF RESEARCH INCPAU20 $47,440,023$46,542,737 CEO$219,877 Same NTEE code U20, revenue within 5x, similar name
SANTA FE INSTITUTENMU20 $51,822,371$16,973,641 PRESIDENT$472,082 Same NTEE code U20, revenue within 5x
KANSAS HEALTH INSTITUTEKSU20 $4,399,442$4,391,764 PRESIDENT$351,653 Same NTEE code U20, revenue within 5x
BUCKMINSTER FULLER INSTITUTECAU20 $5,041,849$2,470,865 Executive Dir.$162,023 Same NTEE code U20, revenue within 5x
SYSTEMS BUILDING RESEARCH ALLIANCENYU20 $4,930,518$1,447,014 TREASURER/SECRETARY$0 Same NTEE code U20, revenue within 5x
OAK CREST INSTITUTE OF SCIENCECAU20 $6,470,203$6,314,850 CEO$248,539 Same NTEE code U20, revenue within 5x
SOUTH CAROLINA RESEARCH FOUNDATIONSCU20 $5,271,618$5,122,804 USC Dean, College of Pharmacy$427,741 Same NTEE code U20, revenue within 5x
AMERICAN FROZEN FOOD INSTITUTEVAU20 $7,322,596$5,933,024 President CEO$706,162 Same NTEE code U20, revenue within 5x
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATIONTNU20 $8,519,357$9,874,862 BOARD MEMBER$0 Same NTEE code U20, revenue within 5x
ASH REGISTRY INCDCU20 $4,973,130$10,038,615 EXECUTIVE DIRECTOR$744,060 Same NTEE code U20, revenue within 5x
HUMAN CELL ATLAS INCMAU20 $5,842,219$5,540,729 CO-CHAIR OF THE BOARD$0 Same NTEE code U20, revenue within 5x
PUBLIC ARCHAEOLOGY LABORATORY INCRIU20 $8,365,042$7,937,630 PRESIDENT$288,934 Same NTEE code U20, revenue within 5x

Who funds organizations like this

Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).

GrantorTotal givenGrantsOrganizations fundedTypeYearsWhich ones
JOHNS HOPKINS UNIVERSITY $80,100,36862 7DAF sponsor2009–2024 RESEARCH TRIANGLE INSTITUTE; GENEVA FOUNDATION 04-15-93; BATTELLE MEMORIAL INSTITUTE; MRIGLOBAL and 3 more
GATES FOUNDATION $79,936,806104 10Private foundation2010–2024 RESEARCH TRIANGLE INSTITUTE; BATTELLE MEMORIAL INSTITUTE; SANTA FE INSTITUTE; MRIGLOBAL and 6 more
DONOR ADVISED CHARITABLE GIVING $29,482,14681 17DAF sponsor2014–2024 SPARK NS INC; SANTA FE INSTITUTE; CLIMATE CENTRAL INC; BUCKMINSTER FULLER INSTITUTE and 13 more
JOHN TEMPLETON FOUNDATION $23,423,37353 3Private foundation2010–2024 WORLD SCIENCE FOUNDATION; SANTA FE INSTITUTE; SOUTH CAROLINA RESEARCH FOUNDATION
GORDON E AND BETTY I MOORE FOUNDATION $18,502,98733 5Private foundation2011–2024 CHABOT SPACE & SCIENCE CENTER FOUNDATION; BATTELLE MEMORIAL INSTITUTE; PUBLIC LIBRARY OF SCIENCE; BUCKMINSTER FULLER INSTITUTE and 1 more
LAURA AND JOHN ARNOLD FOUNDATION $18,395,14448 1Private foundation2020–2024 RESEARCH TRIANGLE INSTITUTE
MITCHELL FAMILY FOUNDATION $13,400,00011 1Private foundation2013–2024 INSTITUTE FOR CREATION RESEARCH
SILICON VALLEY COMMUNITY FOUNDATION $12,326,50846 9DAF sponsor2010–2024 HUMAN CELL ATLAS INC; CLIMATE CENTRAL INC; TECHNOVATION; SANTA FE INSTITUTE and 5 more
FIDELITY INVESTMENTS CHARITABLE GIFT FUND $11,950,22179 18DAF sponsor2016–2024 SANTA FE INSTITUTE; CLIMATE CENTRAL INC; BUCKMINSTER FULLER INSTITUTE; INSTITUTE FOR CREATION RESEARCH and 14 more
THE SCHMIDT FAMILY FOUNDATION $11,375,0008 2Private foundation2020–2024 CLIMATE CENTRAL INC; BUCKMINSTER FULLER INSTITUTE
ONE8 FOUNDATION $9,068,0004 1Private foundation2020–2024 MIND RESEARCH INSTITUTE INC
AMERICAN ONLINE GIVING FOUNDATION INC $8,596,81651 11DAF sponsor2019–2025 MIND RESEARCH INSTITUTE INC; TECHNOVATION; FAJR SCIENTIFIC; EARTHWATCH INSTITUTE INC and 7 more
WILLIAM H MILLER III FOUNDATION INC $7,724,1251 1Private foundation2025–2025 SANTA FE INSTITUTE
JOHN D & CATHERINE T MACARTHUR FOUNDATION $6,801,36017 3Private foundation2010–2023 CLIMATE CENTRAL INC; SANTA FE INSTITUTE; PUBLIC LIBRARY OF SCIENCE
WASHINGTON UNIVERSITY $6,794,43026 3DAF sponsor2009–2024 RESEARCH TRIANGLE INSTITUTE; BATTELLE MEMORIAL INSTITUTE; ST LOUIS SCIENCE CENTER FOUNDATION

The full list · all similar organizations

Where the money went

Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.

2024 · Form 990 · $23,019,000 spent · pay $12,574,000 · grants $0 · events $36,000
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $8,728,000$6,635,000$2,093,000- 37.9%
Other (as described)Subcontracts & Consultants $2,773,000$2,745,000$28,000$0 12.0%
Depreciation and depletion $2,122,000$1,884,000$238,000$0 9.2%
Other (as described)Lab-Operating Supplies & Services $1,999,000$1,999,000$0$0 8.7%
Pay: officers, directors, trustees, key employees $1,689,000$871,000$818,000- 7.3%
Occupancy $1,269,000$1,073,000$196,000$0 5.5%
Other employee benefits $881,000$682,000$199,000- 3.8%
Payroll taxes $717,000$538,000$179,000- 3.1%
Other (as described)Bad Debt $570,000$0$570,000$0 2.5%
Pension plan contributions $559,000$442,000$117,000- 2.4%
Other (as described)Repair and Maintenance $339,000$11,000$328,000$0 1.5%
All other expenses $333,000$62,000$271,000- 1.4%
Insurance $263,000$0$263,000$0 1.1%
Fees: legal $157,000$0$157,000$0 0.7%
Information technology $132,000$99,000$33,000$0 0.6%
Office expenses $104,000$61,000$43,000$0 0.5%
Fees: other services $92,000$72,000$20,000$0 0.4%
Interest $91,000$0$91,000$0 0.4%
Travel $76,000$60,000$16,000$0 0.3%
Fees: accounting $74,000$0$74,000$0 0.3%
Conferences, conventions and meetings $36,000$22,000$14,000$0 0.2%
Fees: investment management $15,000$0$15,000$0 0.1%
Total$23,019,000100%

View the filing

2023 · Form 990 · $27,336,000 spent · pay $13,183,000 · grants $0 · events $34,000
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $7,894,000$5,825,000$2,069,000$0 28.9%
Other (as described)Lab-Operating Supplies & Services $5,033,000$5,033,000$0$0 18.4%
Other (as described)Subcontracts & Consultants $3,834,000$3,814,000$20,000$0 14.0%
Depreciation and depletion $2,314,000$2,059,000$255,000$0 8.5%
Other employee benefits $1,968,000$1,496,000$472,000$0 7.2%
Pay: officers, directors, trustees, key employees $1,858,000$962,000$896,000$0 6.8%
Occupancy $1,447,000$1,167,000$280,000$0 5.3%
Payroll taxes $763,000$572,000$191,000$0 2.8%
Pension plan contributions $700,000$555,000$145,000$0 2.6%
Fees: other services $263,000$247,000$16,000$0 1.0%
Insurance $206,000-$206,000$0 0.8%
All other expenses $206,000$147,000$59,000$0 0.8%
Fees: legal $174,000$0$174,000$0 0.6%
Information technology $131,000$131,000$0$0 0.5%
Office expenses $125,000$70,000$55,000$0 0.5%
Interest $122,000-$122,000$0 0.4%
Travel $97,000$74,000$23,000$0 0.4%
Fees: accounting $84,000$0$84,000$0 0.3%
Other (as described)AR Writeoffs $68,000$0$68,000$0 0.2%
Conferences, conventions and meetings $34,000$20,000$14,000$0 0.1%
Fees: investment management $15,000-$15,000$0 0.1%
Total$27,336,000100%

View the filing

2022 · Form 990 · $25,988,000 spent · pay $13,099,000 · grants $0 · events $0
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $6,556,000$5,268,000$1,288,000$0 25.2%
Other (as described)Lab-Operating Supplies & Services $3,705,000$3,705,000$0$0 14.3%
Other (as described)Subcontracts & Consultants $3,023,000$2,955,000$68,000$0 11.6%
Pay: officers, directors, trustees, key employees $2,758,000$2,206,000$552,000$0 10.6%
Other employee benefits $2,724,000$2,043,000$681,000$0 10.5%
Depreciation and depletion $2,694,000$2,480,000$214,000$0 10.4%
Occupancy $1,660,000$1,273,000$387,000$0 6.4%
Payroll taxes $728,000$546,000$182,000$0 2.8%
Pension plan contributions $333,000$250,000$83,000$0 1.3%
Other (as described)AR Writeoffs $270,000$0$270,000$0 1.0%
Fees: other services $262,000$243,000$19,000$0 1.0%
Insurance $251,000$27,000$224,000$0 1.0%
Travel $186,000$141,000$45,000$0 0.7%
Information technology $170,000$31,000$139,000- 0.7%
Office expenses $155,000$53,000$102,000- 0.6%
Fees: legal $151,000$0$151,000$0 0.6%
All other expenses $139,000$26,000$113,000$0 0.5%
Interest $128,000$0$128,000$0 0.5%
Other (as described)Employee Bonuses $84,000$0$84,000$0 0.3%
Fees: investment management $11,000$0$11,000$0 0.0%
Total$25,988,000100%

View the filing

2021 · Form 990 · $25,493,000 spent · pay $11,694,000 · grants $0 · events $0
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $6,935,000$5,548,000$1,387,000- 27.2%
Other (as described)Lab-Operating Supplies & Services $3,659,000$3,659,000$0$0 14.4%
Other (as described)Subcontracts & Consultants $3,088,000$3,053,000$35,000$0 12.1%
Depreciation and depletion $2,534,000$2,072,000$462,000$0 9.9%
Other employee benefits $2,093,000$1,570,000$523,000- 8.2%
Occupancy $1,526,000$1,315,000$211,000- 6.0%
Pay: officers, directors, trustees, key employees $1,505,000$1,204,000$301,000- 5.9%
Other (as described)Employee Bonus $853,000$611,000$242,000$0 3.3%
Payroll taxes $745,000$559,000$186,000- 2.9%
Other (as described)A/R Writeoff $705,000$0$705,000$0 2.8%
Pension plan contributions $416,000$312,000$104,000$0 1.6%
All other expenses $249,000$115,000$134,000- 1.0%
Fees: other services $245,000$225,000$20,000- 1.0%
Information technology $226,000$18,000$208,000- 0.9%
Insurance $209,000$0$209,000$0 0.8%
Travel $143,000$116,000$27,000- 0.6%
Fees: legal $142,000-$142,000- 0.6%
Fees: accounting $88,000-$88,000- 0.3%
Office expenses $73,000$46,000$27,000- 0.3%
Interest $48,000$0$48,000$0 0.2%
Fees: investment management $11,000-$11,000- 0.0%
Total$25,493,000100%

View the filing

2020 · Form 990 · $25,975,000 spent · pay $11,219,000 · grants $0 · events $0
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $6,325,000$5,091,000$1,234,000$0 24.4%
Other (as described)Subcontractors & Consultants $4,716,000$4,669,000$47,000$0 18.2%
Other (as described)Lab-Operating Supplies & Services $4,249,000$4,249,000$0$0 16.4%
Pay: officers, directors, trustees, key employees $1,933,000$1,556,000$377,000- 7.4%
Depreciation and depletion $1,886,000$1,411,000$475,000$0 7.3%
Other employee benefits $1,880,000$1,410,000$470,000- 7.2%
Occupancy $1,510,000$1,267,000$243,000$0 5.8%
Other (as described)Employee Bonuses $687,000$509,000$178,000$0 2.6%
Payroll taxes $671,000$503,000$168,000$0 2.6%
Pension plan contributions $410,000$308,000$102,000$0 1.6%
Fees: other services $409,000$319,000$90,000- 1.6%
All other expenses $282,000$17,000$265,000$0 1.1%
Other (as described)AR Writeoffs $195,000$0$195,000$0 0.8%
Travel $177,000$158,000$19,000$0 0.7%
Insurance $171,000$0$171,000$0 0.7%
Fees: legal $140,000$0$140,000$0 0.5%
Information technology $130,000$37,000$93,000- 0.5%
Fees: accounting $117,000$0$117,000$0 0.5%
Office expenses $76,000$76,000$0$0 0.3%
Fees: investment management $11,000$0$11,000$0 0.0%
Total$25,975,000100%

View the filing

2019 · Form 990 · $25,017,000 spent · pay $10,871,000 · grants $0 · events $8,000
LineAs describedTotalProgramManagementFundraisingShare
Other salaries and wages $6,831,000$5,119,000$1,712,000$0 27.3%
Other (as described)Subcontractors & consultants $5,291,000$5,285,000$6,000$0 21.1%
Other (as described)Lab-Operating supplies & services $4,066,000$3,688,000$378,000$0 16.3%
Other employee benefits $2,185,000$1,638,000$547,000$0 8.7%
Occupancy $1,942,000$1,859,000$83,000$0 7.8%
Depreciation and depletion $1,559,000$1,308,000$251,000$0 6.2%
Pay: officers, directors, trustees, key employees $799,000$649,000$150,000$0 3.2%
Payroll taxes $626,000$469,000$157,000$0 2.5%
Pension plan contributions $430,000$322,000$108,000$0 1.7%
Other (as described)Employee bonuses $430,000$357,000$73,000$0 1.7%
Other (as described)AR writeoffs $184,000$184,000$0$0 0.7%
Insurance $140,000$0$140,000$0 0.6%
Fees: legal $139,000$0$139,000$0 0.6%
Fees: accounting $128,000$0$128,000$0 0.5%
Travel $91,000$62,000$29,000$0 0.4%
Interest $77,000$0$77,000$0 0.3%
All other expenses $72,000$50,000$22,000$0 0.3%
Fees: investment management $19,000$0$19,000$0 0.1%
Conferences, conventions and meetings $8,000$6,000$2,000$0 0.0%
Total$25,017,000100%

View the filing

Federal grants and contracts

Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.

Fiscal yearGrants and other assistanceContractsAwards
2026$0$3,215,11917
2025$0$1,073,25821
2024$0$5,250,42924
2023$0$4,542,52223
2022$0$2,930,47634
2021$0$4,431,01321
2020-$4,607$4,115,91725
2019$0$2,594,50030
2018$0$8,856,29325
2017$0$8,692,56931
2016$0$9,878,30629
2015$0$8,356,14322
2014$453,776$2,003,01613
2013$438,848$5,002,97321
2012$465,889$27,425,20336
2011$464,897$76,268,56162
2010$374,940$138,550,38764
2009$474,697$106,486,89971
2008$166,995$60,558,805119
2007$466,574$50,498,29278
Largest awards · 200 shown
YearAgencyKindProgramDescriptionObligated
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TASK ORDER AWARD- SSL GLP AND NON-GLP TOXICOLOGY STUDIES$3,391,980
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$559,996
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PA1 TASK ORDER #07$108,506
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TOXICOLOGY STUDIES IN MICE ADMINISTERED MTX-531 - FINAL DELIVERABLES$68,323
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102$59,725
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - 2026 SF IND-ENABLING GLP TOXICOLOGY STUDIES$46,385
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PERFORMANCE AREA 1 TO2$45,779
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS$34,740
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXER-$96
2026National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS-$91,999
2026National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.-$1,008,219
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531$451,034
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES$401,373
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PTTP DRF BPN STUDY - TO3$218,025
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PERFORMANCE AREA 1 TO2$84,588
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$50,726
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$10,025
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF -$6,373
2025National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022-$6,708
2025Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF-$129,432
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531$1,339,008
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF $1,020,618
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$676,144
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102$568,068
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS$512,266
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI -DOG MTD-DRF STUDIES-TO 4$224,716
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PTTP DRF BPN STUDY - TO3$220,123
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2$201,969
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$154,317
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$143,468
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$115,334
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715IITRI - PERFORMANCE AREA 1 TO2$82,128
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXER$36,192
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER-$2,780
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.-$2,907
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013-$2,912
2024National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.-$35,320
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$1,456,819
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.$1,425,732
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013$659,489
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$644,637
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXER$418,720
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$224,185
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$201,709
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION$22,262
2023Food and Drug AdministrationContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF, IN VIVO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS-$1,000
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESCH INSTITUTE:1107221 [18-005715] TO PERFORM THE STUDY "SINGLE PO DOSE CARDIOVASCULAR AND PULMONARY SAFETY PHARMACOLOGY STUDY OF METARRESTIN IN TELEMETERE-$9,390
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TO ISSUE TASK ORDER HHSN27200001, TASK AREA F, BASE IDIQ CONTRACT KICK-OFF-$23,800
2023Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY-$40,073
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESEARCH INSTITUTE:1107221 [18-004523]-$55,529
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF BPN14770 TO SUPPORT PEDIATRIC POPULATION WITH FRAGILE X SYNDROME-$112,474
2023National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESEARCH INSTITUTE:1107221-$268,762
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714PRECLINICAL MICROBIOLOGICAL, SAFETY, TOXICOLOGY, AND PHARMACOKINETIC SERVICES$1,883,524
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS$750,000
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION$743,733
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$698,273
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF $291,405
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$207,287
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$156,564
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.$10,092
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS"$3,000
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.-$1,101
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714"CONTRACT ORIENTATION AND KICKOFF MEETING" UNDER CONTRACT 75N91019D00013-$1,101
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF HHSN2612015000241 PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS-$1,870
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711PRECLINICAL EFFICACY EVALUATION OF THE LIPID-BASED SMEDDS FORMULATION OF DIM, BR-9001, TO AWARD 3-$2,942
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE-$301,031
2022Department of the ArmyContractTESTING LABORATORIES 541380TECHNLOLOGY TRANSFER ASSAYS-$334,926
2022National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR ENDOXIFEN GEL CLINICAL DEVELOPMENT-$524,909
2022Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF ASPR-16-05523 -- TASK ORDER TO IITRI UNDER RTOR BIO-0023 FOR PRODUCTION OF ZIKA VIRUS REGENTS AND ASSAYS-$645,519
2021National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$1,834,370
2021Department of the ArmyContractTESTING LABORATORIES 541380TECHNLOLOGY TRANSFER ASSAYS$981,000
2021National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXER$844,172
2021National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER$535,343
2021National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS$238,571
2021National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715CONTRACT KICK-OFF MEETING FOR NINDS PHARMACOLOGY AND TOXICOLOGY FOR THERAPEUTICS PROGRAM (PTTP)$1,523
2021National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES-$3,965
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022.$1,798,575
2020Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF$637,420
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714COVID-19 RELATED STUDY INVOLVING DOGS$597,893
2020National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICIOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG DEVELOPMEN$588,615
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF $430,361
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021.$323,766
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022$213,180
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020.$153,392
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.$109,619
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE$94,590
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.$87,787
2020Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$84,134
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF CONTRACT ORIENTATION KICKOFF MEETING PP: 9/22/2015 TO 12/31/2015-$703
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER-$2,374
2020National Institutes of HealthGrant or other assistanceCANCER CAUSE AND PREVENTION RESEARCH 93.393DEGUELIN IN THERAPY OF TRIPLE NEGATIVE BREAST CANCER-$4,607
2020Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF-$5,136
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES-$11,950
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710STUDIES TO EVALUATE TOXIC AND CARCINOGENIC POTENTIAL OF CELL PHONE RADIO FREQUENCY RADIATION IN LAB ANIMALS FOR NTP-$441,130
2020National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR THE AEROSOL DEVELOPMENT OF BEXAROTENE HHSN2612015000240 TO: HHSN26100004 POP: 9/18/2017 TO 9/17/2019-$542,120
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020.$1,103,699
2019Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF$726,471
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020.$440,911
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE$193,902
2019Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF$122,161
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR THE AEROSOL DEVELOPMENT OF BEXAROTENE HHSN2612015000240 TO: HHSN26100004 POP: 9/18/2017 TO 9/17/2019$56,577
2019National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690THREE RABBIT STUDY: (1) DOSE RANGE FINDING STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (2) PRELIMINARY EMBRYO FETAL DEVELOPMENTAL STUDY IN RABBITS VIA ORAL GAVA$51,961
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714"CONTRACT ORIENTATION AND KICKOFF MEETING" UNDER CONTRACT 75N91019D00013$3,500
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.$3,500
2019National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES$0
2019Food and Drug AdministrationContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF EFFECTS OF MENTHOL ON ACROLEIN AND CIGARETTE INDUCED LUNG INFLAMMATION-$108,181
2018Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF$1,840,630
2018Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF$1,801,910
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESEARCH INSTITUTE:1107221$1,181,940
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711PRECLINICAL EFFICACY EVALUATION OF THE LIPID-BASED SMEDDS FORMULATION OF DIM, BR-9001, TO AWARD 3$973,931
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712NON-CLINICAL SAFETY ASSESSMENT OF BPN14770 TO SUPPORT PEDIATRIC POPULATION WITH FRAGILE X SYNDROME$902,296
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXER$685,688
2018Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$437,166
2018National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690THREE RABBIT STUDY: (1) DOSE RANGE FINDING STUDY IN RABBITS VIA ORAL GAVAGE (NON-GLP); (2) PRELIMINARY EMBRYO FETAL DEVELOPMENTAL STUDY IN RABBITS VIA ORAL GAVA$435,576
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESEARCH INSTITUTE:1107221 [18-004523]$327,018
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IIT RESCH INSTITUTE:1107221 [18-005715] TO PERFORM THE STUDY "SINGLE PO DOSE CARDIOVASCULAR AND PULMONARY SAFETY PHARMACOLOGY STUDY OF METARRESTIN IN TELEMETERE$139,483
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF HHSN2612015000241 PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS$60,976
2018Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$43,888
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714TO ISSUE TASK ORDER HHSN27200001, TASK AREA F, BASE IDIQ CONTRACT KICK-OFF$26,424
2018National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF NCCIH STUDY ON REPRODUCTIVE TOXICOLOGY STUDIES IN RATS (POTS 16-000765)$20,898
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF EVALUATION OF INOS ANTAGONISTS IN THE PREVENTION OF ORAL CANCER-$22
2018National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF CHEMOPREVENTION OF PROSTATE CANCER VIA ESTROGEN RECEPTOR BETA AGONISTS-$845
2018Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IIT RESEARCH INSTITUTE - DEVELOPMENT OF ANIMAL MODELS TO MEET THE THREATS OF CBRN AGENTS, INFLUENZA, AND EMERGING INFECTIOUS DISEASES IN SUPPORT OF THE PREPARED-$20,661
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR THE AEROSOL DEVELOPMENT OF BEXAROTENE HHSN2612015000240 TO: HHSN26100004 POP: 9/18/2017 TO 9/17/2019$2,597,086
2017Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY$1,655,784
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE$1,582,504
2017Food and Drug AdministrationContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF INHALATION STUDY OF THE IN VIVO TOXICITY OF ESSENTIAL OILS$1,574,100
2017National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS$479,694
2017Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF ASPR-16-05523 -- TASK ORDER TO IITRI UNDER RTOR BIO-0023 FOR PRODUCTION OF ZIKA VIRUS REGENTS AND ASSAYS$267,874
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR ENDOXIFEN GEL CLINICAL DEVELOPMENT$174,815
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711TAS::75 0886::TAS ANIMAL MODELS OF INFECTIOUS DISEASES$100,000
2017Department of the NavyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF AEROSOL GENERATION SYSTEM SETUP PR# 61-0005-17$89,930
2017National Institutes of HealthContractTESTING LABORATORIES 541380IGF::OT::IGF VACCINE EFFICACY IN THE MOUSE MODEL OF H7 INFLUENZA INFECTION$79,500
2017Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY$71,243
2017Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IIT RESEARCH INSTITUTE (TS) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES IGF::OT::IGF$50,000
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711TAS::75 0885::TAS ANIMAL MODELS OF INFECTIOUS DISEASES$50,000
2017Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IIT RESEARCH INSTITUTE (AS) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES IGF::OT::IGF$50,000
2017Office of Assistant Secretary for Preparedness and ResponseContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IIT RESEARCH INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES IGF::OT::IGF$50,000
2017Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$9,889
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF NONCLINICAL SAFETY, TOXICOKINETIC, AND STABILITY EVALUATION OF BIORESPONSE DIINDOLYLMETHANE VAGINAL CREAM FOR TOPICAL TREATMENT CERVICAL INTRAEPITH-$553
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710BIOMEDICAL (APPLIED/EXPLORATORY)-$74,938
2017National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES-$114,356
2016Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$2,183,016
2016Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF ASPR-16-05523 -- TASK ORDER TO IITRI UNDER RTOR BIO-0023 FOR PRODUCTION OF ZIKA VIRUS REGENTS AND ASSAYS$1,540,596
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUPPORT FOR ENDOXIFEN GEL CLINICAL DEVELOPMENT$1,531,900
2016Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY$1,402,616
2016Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF FOR OTHER FUNCTIONS$1,007,222
2016Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$987,845
2016National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF NCCIH STUDY ON REPRODUCTIVE TOXICOLOGY STUDIES IN RATS (POTS 16-000765)$610,874
2016Food and Drug AdministrationContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF EFFECTS OF MENTHOL ON ACROLEIN AND CIGARETTE INDUCED LUNG INFLAMMATION$465,680
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF HHSN2612015000241 PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS$262,005
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES$61,056
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF IIT RESCH INSTITUTE:1107221 [16-053307]$16,200
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710BIOMEDICAL (APPLIED/EXPLORATORY)$8,415
2016National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690IGF::OT::IGF TO#1 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS HHSN261201600015I DTP-16-054 TPB$4,145
2016National Institutes of HealthContractALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990IGF::OT::IGF KICK OFF MEETING, PRECLINICAL PHARMACOKINETIC&PHARMACOLOGY EVALUATIONS OF AGENTS BEING DEVELOPED FOR CANCER PATIENTS, 7/1/2016 - 9/30/16$1,010
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL TOXICOLOGY AND PHARMACOLOGY OF DRUGS-$26,281
2016National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710STUDIES TO EVALUATE TOXIC AND CARCINOGENIC POTENTIAL OF CELL PHONE RADIO FREQUENCY RADIATION IN LAB ANIMALS FOR NTP-$177,992
2015National Institutes of HealthContract 541710STUDIES TO EVALUATE TOXIC AND CARCINOGENIC POTENTIAL OF CELL PHONE RADIO FREQUENCY RADIATION IN LAB ANIMALS FOR NTP$3,549,647
2015Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF FOR OTHER FUNCTIONS$2,219,193
2015Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY$1,415,081
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER$598,583
2015Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF$570,858
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES$236,727
2015Office of Assistant Secretary for Preparedness and ResponseContractBIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING 325414IGF::OT::IGF FOR OTHER FUNCTIONS PROJECT: EFFICACY STUDIES OF AB103 AGAINST LETHAL CHALLENGE OF STAPHYLOCOCCAL ENTEROTOXIN B (SEB) IN C3H/HEJ MICE$128,233
2015National Institutes of HealthContractALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990NCATS IIT RESEARCH DOSE RANGE FINDING IN MICE IGF::CL::IGF$119,495
2015National Institutes of HealthContract 541710BIOMEDICAL (APPLIED/EXPLORATORY)$25,410
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF CONTRACT ORIENTATION KICKOFF MEETING PP: 9/22/2015 TO 12/31/2015$4,520
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF CONTRACT ORIENTATION AND KICKOFF MEETING 9/30 TO 12/31/2015$1,024
2015Food and Drug AdministrationContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712IGF::OT::IGF, IN VIVO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS$1,000
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711TAS::75 0885::TAS ANIMAL MODELS OF INFECTIOUS DISEASES-$50,000
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711TAS::75 0886::TAS ANIMAL MODELS OF INFECTIOUS DISEASES-$100,000
2015National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL TOXICOLOGY AND PHARMACOLOGY OF DRUGS-$363,627
2014Department of the ArmyContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY$1,403,327
2014National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES$924,326
2014National Institutes of HealthGrant or other assistanceCANCER CAUSE AND PREVENTION RESEARCH 93.393DEGUELIN IN THERAPY OF TRIPLE NEGATIVE BREAST CANCER$453,776
2014Department of the ArmyContract 541710200211!000732!2100!MD17 !US ARMY MEDICAL RESEARCH ACQ ACT!DAMD1702C0101 !A!N! !N! !20020604!20041130!005447826!005447826!005447826!N!IIT RES$8,722
2014National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL PHARMACOLOGY AND TOXICOLOGY STUDIES$0
2014National Institutes of HealthContractOTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690TAS::75 0886::TAS NON-HUMAN PRIMATE STUDY FOR FDA REGULATORY APPROVAL TO BEGIN HUMAN TRIALS-$333,358
2013Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$930,861
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712TAS::75 0849::TAS PRECLINICAL TOXICOLOGY STUDIES$885,185
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF CHEMOPREVENTION OF PROSTATE CANCER VIA ESTROGEN RECEPTOR BETA AGONISTS$686,259
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF EVALUATION OF INOS ANTAGONISTS IN THE PREVENTION OF ORAL CANCER$621,261
2013Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$495,050
2013National Institutes of HealthContract 541710STUDIES TO EVALUATE TOXIC AND CARCINOGENIC POTENTIAL OF CELL PHONE RADIO FREQUENCY RADIATION IN LAB ANIMALS FOR NTP$465,060
2013National Institutes of HealthGrant or other assistanceCANCER CAUSE AND PREVENTION RESEARCH 93.393DEGUELIN IN THERAPY OF TRIPLE NEGATIVE BREAST CANCER$438,848
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DEVELOPMENT$425,100
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL PHARMACOLOGY AND TOXICOLOGY STUDIES$245,283
2013Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$231,151
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711IGF::OT::IGF NONCLINICAL SAFETY, TOXICOKINETIC, AND STABILITY EVALUATION OF BIORESPONSE DIINDOLYLMETHANE VAGINAL CREAM FOR TOPICAL TREATMENT CERVICAL INTRAEPITH$165,842
2013Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$110,219
2013Agricultural Research ServiceContractTESTING LABORATORIES 541380IGF::OT::IGF ACUTE ORAL TOXICITY/PATHOGENICITY TESTING FROM INDEPENDENT LABORATORY.$71,049
2013National Institutes of HealthContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710PRECLINICAL TOXICOLOGY AND PHARMACOLOGY OF DRUGS$0
2013National Institutes of HealthContract 541710BIOMEDICAL (APPLIED/EXPLORATORY)-$164,672
2013National Institutes of HealthContract 541710EVALUATION OF CANDIDATE SMALLPOX VACCINES IN IMMUNE DEFICIENT MOUSE MODELS-$164,672
2012Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$5,458,114
2012Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$3,535,490
2012Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$3,454,556
2012Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$3,321,972
2012Department of the Air ForceContractRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES 541710TECHNICAL AREA TASKS$2,740,561

State business registration

The same business name in the same state, from the state’s official registry data.

Patents

2 US patents filed in the last 20 years.

PatentTitleGrantedSource
US 12281060Remodilins for airway remodeling and organ fibrosis2025-04-22PVGPATDIS, file of 2026-04-10
US 12280038L-pag derivatives for treatment of sleep disordered breathing (SDB)2025-04-22PVGPATDIS, file of 2026-04-10

The newest patents of the PatentsView assignees above, matched to this record by name (and state).

Trademarks

1 US trademark, 1 live.

MarkSerialFiledStatusSource
IITRI774111312008-03-03Registered and renewedTRCFECO2, file of 2024-03-27

The newest marks of the trademark owners above, matched to this record by name (and state).

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationIIT Research InstituteILState business registriesname and state
Business registrationIIT RESEARCH INSTITUTEILState business registriesname and state
Business registrationIIT RESEARCH INSTITUTE (CORPORATION)ILState business registriesname and state
Business registrationIIT RESEARCH INSTITUTE INCORPORATEDILState business registriesname and state
ContractorIIT RESEARCH INSTITUTEILNonprofit contractors (Form 990)name and state
Plan sponsorIIT RESEARCH INSTITUTEILForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientIIT RESEARCH INSTITUTEILFederal spending (USAspending)name and state
Patent assigneeIIT Research InstituteILPatents (USPTO)name and state
Trademark ownerIIT Research InstituteILTrademarks (USPTO)name and state
Wikipedia articleIIT Research InstituteWikipedia (English)FUZZY: the same website address and the same name

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

NTEE code General Science, IL first:

More with this interest.

In other datasets, the same topic (Science) in IL:

Interests: General Science · science:research_education · Science

The area Census

Cook CountyChicago cityCensus Tract 8411

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Census Tract 8411, Cook County, Illinois, place (city or town) Chicago, IL, county Cook County, IL, state Illinois; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).

  • David McCormick was paid $581,526, 7.5 times the median household income in Chicago, IL ($77,902), where 16.8% of residents live in poverty.
  • Revenue of $17,520,000 is $6 per resident of Chicago, IL (population 2,711,226).
  • That revenue equals 0.02% of all household income in Chicago, IL (1,160,205 households at the median $77,902, about $90,382,289,910).
  • 128 employees is 0.0 per 1,000 residents of Chicago, IL.
MeasureCensus tract
Census Tract 8411, Cook County, Illinois
Place (city or town)
Chicago, IL
County
Cook County, IL
State
Illinois
Population B010037,3242,711,2265,182,09012,694,798
Population, 2020 census P17,3562,746,3885,275,54112,812,508
Median age B0100248.735.838.039.0
Under 18 B0100113.7%19.4%21.1%21.8%
65 and over B0100119.7%13.8%16.0%17.0%
Households B110012,8751,160,2052,100,2305,036,449
Foreign born B0500260.1%20.9%21.7%14.7%
Median household income B19013$44,083$77,902$83,498$83,390
Median family income B19113$66,912$95,774$104,836$106,018
Per capita income B19301$29,216$50,086$49,329$46,406
Poverty rate B1700120.1%16.8%13.5%11.8%
Unemployment rate B2302510.2%8.0%7.0%5.8%
Civilian labor force B230254,1181,517,3302,792,8886,652,134
Mean commute (minutes) B0801326.533.131.527.8
Bachelor's degree or higher B1500325.6%44.3%42.7%37.8%
Housing units B250013,0251,277,0542,276,4935,457,452
Owner-occupied B2500341.2%46.0%57.7%67.1%
Renters B2500358.8%54.0%42.3%32.9%
Median home value B25077$354,600$334,100$324,500$263,300
Median gross rent B25064$1,286$1,440$1,435$1,274
White, not Hispanic B030025.7%32.1%40.1%58.1%
Black B030023.7%27.4%21.8%13.3%
Hispanic or Latino B030022.6%29.7%26.8%18.8%
Asian B0300285.3%7.2%7.9%5.9%
American Indian and Alaska Native B030020.9%0.1%0.1%0.1%

Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); Unemployment rate: 5.7% in Sep 2016 to 4.6% in Sep 2026; low 3.6%, high 18.3% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 8411, Cook County, Illinois.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.